Perrigo | PRGO

Perrigo traded at $33.32 this Thursday March 23rd, decreasing $0.66 or 1.94 percent since the previous trading session. Looking back, over the last four weeks, Perrigo lost 8.11 percent. Over the last 12 months, its price fell by 12.45 percent. Looking ahead, we forecast Perrigo to be priced at 33.45 by the end of this quarter and at 29.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
33.32
Daily Change
-1.94%
Yearly
-12.45%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 155.30 1.63 1.06% -3.11%
Abbott 97.04 0.18 0.19% -17.64%
Bayer 56.02 -0.61 -1.08% -5.90%
Bristol-Myers Squibb 66.97 -0.27 -0.40% -7.51%
Coherus Biosciences 5.89 0 0% -54.31%
Corcept Therapeutics 21.15 0.31 1.49% -12.31%
Catalent 62.70 -1.95 -3.02% -41.90%
Dr.Reddys Laboratories 4,454.60 -20.35 -0.45% 2.91%
Endo International 0.08 -0.003 -4.07% -96.81%
Horizon Pharma 107.81 0.49 0.46% -1.82%
Jazz Pharmaceuticals 137.37 -1.09 -0.79% -13.93%
J&J 151.27 0.22 0.15% -13.68%
Lannett 1.69 -0.07 -3.98% 104.38%
Eli Lilly 333.02 2.05 0.62% 15.76%
Merck & Co 104.23 -0.02 -0.02% 29.62%
Nestle 109.50 -0.16 -0.15% -8.69%
Phibro Animal Health 14.53 -0.25 -1.69% -26.62%
Prestige Brands 60.98 0.02 0.03% 13.47%
Pacira 38.60 -0.73 -1.86% -48.95%
Pfizer 40.06 0.20 0.50% -23.83%
Powershares High Yield Orate Bond Portfolio 17.17 -0.03 -0.17% -6.02%
Perrigo 33.32 -0.66 -1.94% -12.45%
Reckitt Benckiser Group PLC 6,006.36 -15.64 -0.26% 6.59%
Sanofi 95.64 4.78 5.26% 2.63%
Supernus Pharmaceuticals 34.85 -0.51 -1.44% 8.00%
Teva Pharmaceutical Industries Ltd 3,250.00 21.00 0.65% 24.05%
United States Oil Fund 61.11 -0.50 -0.81% -23.37%
Xeris Pharmaceuticals Inc 1.28 -0.05 -3.41% -55.57%
Zoetis 161.31 -0.07 -0.04% -14.91%

Indexes Price Day Year
US400 2386 -9.85 -0.41% -11.40%

Perrigo
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.